DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

Information source: Alcon Research
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Seasonal Allergic Rhinitis

Intervention: Olopatadine Hydrochloride Nasal Spray 0.6% (Drug); Vehicle (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Alcon Research

Official(s) and/or principal investigator(s):
Ed Tumaian, Study Director, Affiliation: ed.tumaian@alconlabs.com

Summary

A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis.

Clinical Details

Official title: Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Percent Change From Baseline in the Reflective Total Nasal Symptom Score (TNSS)

Secondary outcome: Percent Change From Baseline in the Reflective Total Ocular Symptom Score (TOSS)

Eligibility

Minimum age: 6 Years. Maximum age: 11 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Male or female; minimum of 6 years of age and less than 12 years

- 2 year history of seasonal allergic rhinitis

Exclusion Criteria:

- Concurrent disease that might interfere with the investigation or evaluation of te

study medication

- Confirmed diagnosis of chronic rhinosinusitis within the last year

- Asthma, with the exception of mild intermittent asthma

- Anatomical nasal deformity

- Nasal obstruction

- Known non-responder to antihistamines for symptoms of Seasonal Allergic Rhinitis

(SAR)

- Chronic or intermittent use of of inhaled, oral, intramuscular intravenous

corticosteroids ot topical steroids

- Ocular disorder other that allergic conjunctivitis

Locations and Contacts

Kenilworth/IL, Kenilworth, Illinois 60043, United States
Additional Information

Starting date: September 2007
Last updated: February 23, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017